Explaining fatigue in ANCA-associated vasculitis

Explaining fatigue in ANCA-associated vasculitis

Εμφάνιση άλλων εκδόσεων (1)

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Basu, N, McClean, A, Harper, L, Amft, E, Dhaun, N, Luqmani, R, Little, M, Jayne, D, Flossmann, O, McLaren, J, Kumar, V, Erwig, L, Reid, D, Macfarlane, G, Jones, G
Μορφή:	Journal article
Έκδοση:	2013

Παρόμοια τεκμήρια

Explaining fatigue in ANCA-associated vasculitis.
ανά: Basu, N, κ.ά.
Έκδοση: (2013)

CONTEXTUALISING QUALITY OF LIFE IN ANCA ASSOCIATED VASCULITIS (AAV)
ανά: Basu, N, κ.ά.
Έκδοση: (2012)

The characterisation and determinants of quality of life in ANCA associated vasculitis
ανά: Basu, N, κ.ά.
Έκδοση: (2014)

The characterisation and determinants of quality of life in ANCA associated vasculitis.
ανά: Basu, N, κ.ά.
Έκδοση: (2014)

Determinants of Poor Quality of Life in ANCA Associated Vasculitis (AAV).
ανά: Basu, N, κ.ά.
Έκδοση: (2012)

Markers for work disability in ANCA-associated vasculitis
ανά: Basu, N, κ.ά.
Έκδοση: (2013)

Markers for work disability in anti-neutrophil cytoplasmic antibody-associated vasculitis.
ανά: Basu, N, κ.ά.
Έκδοση: (2014)

Cardiovascular disease incidence and risk factors in ANCA-associated primary systemic vasculitis (AASV)
ανά: Salisbury, E, κ.ά.
Έκδοση: (2003)

INCIDENCE OF NON-FATAL CLINICAL CORONARY EVENTS IN PRIMARY ANCA-ASSOCIATED SYSTEMIC VASCULITIS (AASV)
ανά: Salisbury, E, κ.ά.
Έκδοση: (2003)

CARDIOVASCULAR AND CEREBROVASCULAR DISEASE INCIDENCE AND RISK FACTORS IN ANCA-ASSOCIATED PRIMARY SYSTEMIC VASCULITIS (AASV)
ανά: Salisbury, E, κ.ά.
Έκδοση: (2004)

Cardiovascular outcomes in ANCA associated vasculitis
ανά: Mukhtyar, C, κ.ά.
Έκδοση: (2008)

Incidence of non-fatal clinical coronary events in primary ANCA-associated systemic vasculitis (aasv)
ανά: Salisbury, E, κ.ά.
Έκδοση: (2003)

DEVELOPMENT OF DIAGNOSTIC CRITERIA FOR PRIMARY ANCA-ASSOCIATED SYSTEMIC VASCULITIS (AASV)
ανά: McLaren, J, κ.ά.
Έκδοση: (2003)

THE PROGNOSTIC VALUE OF THE BIRMINGHAM VASCULITIS ACTIVITY SCORE AND THE VASCULITIS DAMAGE INDEX IN ANCA-ASSOCIATED VASCULITIS
ανά: Suppiah, R, κ.ά.
Έκδοση: (2011)

Long-term survival of ANCA-associated vasculitis
ανά: Flossmann, O, κ.ά.
Έκδοση: (2009)

EULAR recommendations for conducting clinical studies and/or clinical trials in ANCA-associated vasculitis
ανά: Luqmani, R, κ.ά.
Έκδοση: (2007)

DIAGNOSTIC CRITERIA FOR ANCA-ASSOCIATED PRIMARY SYSTEMIC VASCULITIS (AASV) IN PATIENTS PRESENTING WITH ACUTE PULMONARY AND/OR RENAL DISEASE
ανά: McLaren, J, κ.ά.
Έκδοση: (2004)

Positive predictive value of anti-neutrophil cytoplasmic antibody (ANCA) testing for ANCA-associated systemic vasculitis (AASV) in a routine clinical setting
ανά: McLaren, J, κ.ά.
Έκδοση: (2001)

Long-term patient survival in ANCA-associated vasculitis
ανά: Flossmann, O, κ.ά.
Έκδοση: (2011)

Long-term patient survival in ANCA-associated vasculitis.
ανά: Flossmann, O, κ.ά.
Έκδοση: (2011)

Diagnosis and management of ANCA associated vasculitis.
ανά: Berden, A, κ.ά.
Έκδοση: (2012)

Long-term patient survival in ANCA-associated vasculitis.
ανά: Flossmann, O, κ.ά.
Έκδοση: (2011)

A four year analysis of variation in use of the anti-neutrophil cytoplasmic antibody (ANCA) test as a screening tool for ANCA-associated systemic vasculitis (AAV) in a teaching hospital.
ανά: McLaren, J, κ.ά.
Έκδοση: (2000)

TREATMENT-RELATED DAMAGE IN THE ANCA-ASSOCIATED VASCULITIDES: AN ANALYSIS OF THE EUROPEAN VASCULITIS STUDY GROUP THERAPEUTIC TRIALS
ανά: Robson, J, κ.ά.
Έκδοση: (2013)

Damage in the anca-associated vasculitides: long-term data from the European Vasculitis Study group (EUVAS) therapeutic trials.
ανά: Robson, J, κ.ά.
Έκδοση: (2015)

Damage in the ANCA-associated vasculitides: Long-term data from the European Vasculitis Study Group (EUVAS) therapeutic trials
ανά: Robson, J, κ.ά.
Έκδοση: (2015)

BSR and BHPR guidelines for the management of adults with ANCA associated vasculitis.
ανά: Lapraik, C, κ.ά.
Έκδοση: (2007)

BSR and BHPR guideline for the management of adults with ANCA-associated vasculitis.
ανά: Ntatsaki, E, κ.ά.
Έκδοση: (2014)

Predictors of renal involvement in ANCA associated vasculitis
ανά: Kronbichler, A, κ.ά.
Έκδοση: (2018)

Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials
ανά: Suppiah, R, κ.ά.
Έκδοση: (2011)

Damage assessment in ANCA-associated vasculitis.
ανά: Bhamra, K, κ.ά.
Έκδοση: (2012)

Peripheral neuropathy in ANCA-associated vasculitis: outcomes from the European Vasculitis Study Group trials.
ανά: Suppiah, R, κ.ά.
Έκδοση: (2011)

FACTORS ASSOCIATED WITH LONG-TERM DAMAGE IN THE ANCA-ASSOCIATED VASCULITIDES: AN ANALYSIS OF COHORTS FROM THE EUROPEAN VASCULITIS STUDY GROUP THERAPEUTIC TRIALS
ανά: Robson, J, κ.ά.
Έκδοση: (2013)

Maintenance of clinical remission in ANCA-associated vasculitis.
ανά: Luqmani, R
Έκδοση: (2013)

Outcome measures in ANCA-associated vasculitis.
ανά: Suppiah, R, κ.ά.
Έκδοση: (2010)

The UK & Ireland Vasculitis Registry (UKIVAS): Cross-sectional data on the first 2290 Patients with anti-neutrophil cytoplasm (ANCA) associated vasculitis (AAV)
ανά: Luqmani, R, κ.ά.
Έκδοση: (2017)

Comparison of disease activity measures for ANCA-associated vasculitis.
ανά: Merkel, P, κ.ά.
Έκδοση: (2004)

Diagnosis and assessment of systemic vasculitis.
ανά: McLaren, J, κ.ά.
Έκδοση: (2002)

A multi-centre randomised trial of cyclophosphamide versus azathioprine during remission in ANCA-associated systemic vasculitis (Cycazarem).
ανά: Luqmani, R, κ.ά.
Έκδοση: (1999)

Opinion: Maintenance of clinical remission in ANCA-associated vasculitis
ανά: Luqmani, R
Έκδοση: (2013)